Share This Article:

Comparison of the Palatability of a New Flavoured Drontal® Plus Tablet (Drontal® Plus Treat 10 kg) and Milbemax® Chewable Tablets When Presented to Privately Owned Dogs

Abstract Full-Text HTML Download Download as PDF (Size:2500KB) PP. 163-169
DOI: 10.4236/ojvm.2014.48018    2,801 Downloads   3,540 Views   Citations


There is an increased need for highly palatable oral dosage forms for dogs and cats, especially in the case of regular or chronic medications. To meet this need of easy application, the original Drontal® Plus tablet, a broad-spectrum anthelminthic, was optimized using a novel formula. A field study was conducted to evaluate the palatability of this new Drontal® Plus formula in comparison to a positive control product (Milbemax® Chewable Tablets) with a well-known high palatability. The study also aimed to get a palatability claim which necessitates the conduct of appropriate studies. 150 privately owned dogs of 38 pure or mixed breeds, six months to twelve years old, and with a weight range of 5 to 50 kg were included. The study was based on a cross-over design, and a standardized acceptance test was used to evaluate and compare the palatability of the two medications. In this study 88% of dogs voluntarily consumed Drontal® Plus Treat 10 kg, and 86.7% accepted Milbemax® Chewable Tablets. In the majority of cases (IVP: 98%, CP: 95%) the tablets were taken directly from the owner’s hand. The new Drontal® Plus tablet showed a high palatability compared to the Milbemax® Chewable Tablets when used in a household study design with privately owned dogs.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Petry, G. , Fourie, J. and Wolken, S. (2014) Comparison of the Palatability of a New Flavoured Drontal® Plus Tablet (Drontal® Plus Treat 10 kg) and Milbemax® Chewable Tablets When Presented to Privately Owned Dogs. Open Journal of Veterinary Medicine, 4, 163-169. doi: 10.4236/ojvm.2014.48018.


[1] EMA, EMA/CVMP/EWP/206024/2011-Consultation (2014) Guideline on the Demonstration of Palata-
bility of Veterinary Products.
[2] Smith, J.C., Rashotte, M.E., Austin, T. and Griffin, R.W. (1984) Fine-Grained Measures of Dogs’ Eating Behavior in Single-Pan and Two-Pan Tests. Neuroscience and Biobehavioral Reviews, 8, 243-251.
[3] Payne-Johnson, M., Maitland, T.P., Bullard, J. and Gosselin, J. (2006) Comparative Palatability of Three Commercial Formulations of Carprofen and One Commercial Formulation of Firocoxib in Dogs. Revue de Médecine Vétérinaire, 157, 431-440.
[4] Payne-Johnson, M., Maitland, T.P., Tilt, N. and Gosselin, J. (2007) An Evaluation of the Relative Palatability of Two Commercial Oral Tablet Formulations of Carprofen and Meloxicam in Dogs Using Acceptance and Preference Tests. Revue de MédecineVétérinaire, 158, 519-524.
[5] Gossellin, J., Maitland, T.P. and Civil, J. (2010) Relative Preference of Dogs for Two Commercial Oral Tablet Formulations of Carprofen. Revue de MédecineVétérinaire, 161, 67-71.
[6] Griffin R.W., Scott, G.C. and Cante C.J. (1984) Food Preferences of Dogs Housed in Testing-Kennels and in Consumers’ Homes: Some Comparisons. Neuroscience and Biobehavioral Reviews, 8, 253-259.
[7] Thombre, A.G. (2004) Oral Delivery of Medications to Companion Animals: Palatability Considerations. Advanced Drug Delivery Reviews, 56, 1399-1413.
[8] Zemirline, C., Beranger, J., Gobbi, S. and Cissay, E. (2009) Comparative Palatability of a New Formulation and Two Commercial Formulations of Benazepril in Dogs. Revue de Médecine Vétérinaire, 160, 275-381.
[9] Marshall-Pescini, S., Prato-Previde, E. and Valsecchi, P. (2011) Are Dogs (Canis familaris) Misled More by Their Owners Than by Strangers in a Food Choice Task? Animal Cognition, 14, 137-142.
[10] Waterhouse, H.N. and Fritsch, C.W. (1967) Dog Food Palatability Tests and Sources of Potential Bias. Laboratory Animal Care, 17, 93-102.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.